Beta: Sign in
Shares outstandingAs of 2026-09-30 · filed common shares: 109.24M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.16%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 16.44%
Short ratioDays to cover, as published by FINRA: 15.94
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 52.10%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 49.70%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for NRIX

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginTTM to Aug 26: 41.27%
Net margin: —
EBITDA marginTTM to Aug 26: 42.51%
Return on equityNet income (TTM to Aug 26) ÷ average shareholders equity: 43.99%
Return on assetsNet income (TTM to Aug 26) ÷ average total assets: 34.33%

Growth

Revenue growth (annual YoY): 53.95%
Revenue growth (latest qtr YoY): 8426.27%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Aug 26: 2.43
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Aug 26: $720.24M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Aug 26: $65.33M
Debt / equityas of Aug 26: 6.75%
Current ratioas of Aug 26: 8.44
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Aug 26: 5.66
Operating cash flowTTM to Aug 26: $379.31M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Aug 26: $369.80M
TTM revenue / diluted shareDiluted, TTM to Aug 26: 6.49

NRIX stock Statistics — Nurix Therapeutics, Inc. filings, insiders & smart money · Instaport